Streetbeat News

Stock Prices

BANR

Raymond James analyst David Feaster has maintained an Outperform rating on Banner Corporation (NASDAQ:BANR) and increased the price target from $47 to $51.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 12:43 pm

COUR

Goldman Sachs analyst Eric Sheridan has maintained a Sell rating on Coursera (NYSE:COUR) and reduced the price target from $18 to $14.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 12:42 pm

AMRN

Amarin's Chairman and CEO have issued a letter to shareholders stating that the company possesses significant unrealized value that is not currently reflected in its stock price.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 12:37 pm

CHGG

Goldman Sachs analyst Eric Sheridan has reiterated a Sell rating on Chegg (NYSE:CHGG) and reduced the price target from $10 to $8.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 12:37 pm

AY

HE

NWE

Analysts have rated three high-yield dividend stocks in the utilities sector. Hawaiian Electric Industries (HE) has an 11.32% yield but received an Underperform and Equal-Weight rating. Atlantica Sustainable Infrastructure (AY) offers a 9.20% yield and was downgraded to Market Perform with a Neutral rating. NorthWestern Energy Group (NWE) with a 5.40% yield was upgraded to Overweight but also received an Underweight rating. All companies recently reported their quarterly earnings.

Portfolio Pulse from Avi Kapoor

January 22, 2024 | 12:35 pm

CLSD

INO

IOBT

ONCT

SOPH

Five health care stocks with high RSI values, indicating potential overbought conditions, may face a downturn. SOPHiA GENETICS (SOPH), Inovio Pharmaceuticals (INO), Oncternal Therapeutics (ONCT), Clearside Biomedical (CLSD), and IO Biotech (IOBT) have all seen significant price movements and are now showing RSI values above 70, which could signal a short-term pullback in their stock prices.

Portfolio Pulse from Avi Kapoor

January 22, 2024 | 12:34 pm

ECOR

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains a Buy rating on electroCore (NASDAQ:ECOR) and increases the price target from $11 to $15.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 12:33 pm

CVX

HES

Chevron Corp (NYSE:CVX) is looking to sell its natural gas business in Canada's Duvernay Shale, which produces around 40,000 barrels of oil and gas daily. The sale is part of Chevron's strategy to streamline operations after several acquisitions, including deals with Hess Corp (NYSE:HES), PDC Energy, and Noble Energy. The assets could be worth up to $900 million. Chevron plans to divest $10 billion to $15 billion in assets by 2028. The company will report Q4 FY24 results on February 2, 2024. CVX shares saw a slight premarket decline.

Portfolio Pulse from Lekha Gupta

January 22, 2024 | 12:33 pm

CARA

Cara Therapeutics is reallocating its resources to concentrate on the oral difelikefalin Phase 2/3 program for treating notalgia paresthetica. The company is also reducing its operating expenses, which will extend its cash runway into 2026.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 12:30 pm

COIN

GS

QCOM

USB

Insiders at Goldman Sachs, QUALCOMM, U.S. Bancorp, and Coinbase Global have recently sold shares of their companies. Goldman Sachs is expanding its asset and wealth management divisions, while QUALCOMM received a price target increase from Canaccord Genuity. U.S. Bancorp reported Q4 revenue that missed analyst expectations, and Coinbase's price target was raised by Citigroup. Insider sales can indicate various sentiments and should not be the sole basis for investment decisions.

Portfolio Pulse from Avi Kapoor

January 22, 2024 | 12:25 pm